AstraZeneca warning: Clotting cases ‘confined to younger women’ as new concerns emerge

AstraZeneca: Blood clots 'confined to younger women' says expert

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

Sir Kent Woods, former Chief Executive of Medicines and Healthcare Products Regulatory Agency (MHRA), was commenting after Germany once again suspending the use of the Anglo-Swedish vaccine to all people under the age of 60. The AstraZeneca vaccine has faced repeated challenges from EU states over safety concerns following reports of blood clotting in a small number of cases. Sir Kent described the move by Berlin as “precautionary” and added that the clotting cases are “confined to younger women.” 

He said: “I think this is a highly precautionary step on the part of the German authorities.

“It runs counter to the advice of the European medicines Agency as been giving in relation to this vaccine.

“The caution I think is based on the pattern of blood clotting that has been reported in these very small number of cases.

“There are many things we still don’t know about this.”

More to follow.

Source: Read Full Article